Possible ameliorating effect of isoquercetin on diethylnitrosamine-induced hepatocellular carcinoma in albino mice

References

• Rasool M, Rashid S, Arooj M, et al. New possibilities in hepatocellular carcinoma treatment. Anticancer Res. 2014;34(4):1563–1571.
   PubMed Web of Science ®Google Scholar
• International agency for research on cancer globocan: cancer fact sheets. (2020) https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf. (cited 2020 May 18).
   Google Scholar
• Hiraoka A, Kawamura T, Aibiki T, et al. Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy. Eur J Radiol. 2015;84(3):366–371.
   Google Scholar
• El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterol. 2008;134(6):1752–1763.
   PubMed Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314.
   PubMed Web of Science ®Google Scholar
• Jung KH, Rumman M, Yan H, et al. An ethyl acetate fraction of Artemisia capillaris (ACE‐63) induced apoptosis and anti‐angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma. Phytother Res. 2018;32(10):2034–2046.
   Google Scholar
• Ren F, Li J, Yuan X, et al. Dandelion polysaccharides exert anticancer effect on hepatocellular carcinoma by inhibiting PI3K/AKT/mTOR pathway and enhancing immune response. J Funct Foods. 2019;55:263–274‏.
   Google Scholar
• Kefayat A, Ghahremani F, Safavi A, et al. Spirulina extract enriched for braun‐type lipoprotein (Immulina®) for inhibition of 4T1 breast tumors’ growth and metastasis. Phytother Res. 2020;34(2):368–378.
   Google Scholar
• Mahmoud YI, Shehata AM, Fares NH, et al. Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis. Life Sci. 2021;265:118827.
   Google Scholar
• Zhou J, Yoshitomi H, Liu T, et al. Isoquercitrin activates the AMP–activated protein kinase (AMPK) signal pathway in rat H4IIE cells. BMC Complement Altern Med. 2014;14(1):42.
   Google Scholar
• Ran J, Wang Y, Zhang W, et al. Research on the bioactivity of isoquercetin extracted from marestail on bladder cancer EJ cell and the mechanism of its occurrence. Artif Cells Nanomed Biotechnol. 2016;44(3):859–864.
   PubMed Web of Science ®Google Scholar
• Huang G, Tang B, Tang K, et al. Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. Oncol Rep. 2014;31(5):2377–2384.
   PubMed Web of Science ®Google Scholar
• Chen Q, Li P, Xu Y, et al. Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activated protein kinase signalling pathway. Oncol Rep. 2015;33(2):840–848.
   PubMed Web of Science ®Google Scholar
• Li S, Tan HY, Wang N, et al. The potential and action mechanism of polyphenols in the treatment of liver diseases. Oxid Med Cell Longev. 2018;2018 .
   Google Scholar
• Shui L, Wang W, Xie M, et al. Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway. Aging (Albany NY). 2020;12(23):24318‏.
   Google Scholar
• Qin G, Ma J, Huang Q, et al. Isoquercetin improves hepatic lipid accumulation by activating AMPK pathway and suppressing TGF-β signaling on an HFD-induced nonalcoholic fatty liver disease rat model. Int J Mol Sci. 2018;19(12):4126.
   PubMed Web of Science ®Google Scholar
• Chen GL, Fan MX, Wu JL, et al. Antioxidant and anti-inflammatory properties of flavonoids from lotus plumule. Food Chem. 2019;277:706–712.
   PubMed Web of Science ®Google Scholar
• Liang S, Xu Z, Ruan Y, et al. Isoquercitrin attenuates renal ischemia/reperfusion injury through antioxidation, anti-inflammation, and antiapoptosis in mice. Transplant Proc. 2020;52(3):1014–1019.
   Google Scholar
• Park HJ, Kim HN, Kim CY, et al. Synergistic protection by isoquercitrin and quercetin against glutamate-induced oxidative cell death in HT22 cells via activating nrf2 and HO-1 signaling pathway: neuroprotective principles and mechanisms of dendropanax morbifera leaves. Antioxidants. 2021;10(4):554.
   Google Scholar
• Xie W, Chen C, Jiang Z, et al. Apocynum venetum attenuates acetaminophen-induced liver injury in mice. Am J Chin Med. 2015;43(3):457–476‏.
   Google Scholar
• Huang XL, He Y, Ji LL, et al. Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats. Oncotarget. 2017;8(60):101545.
   Google Scholar
• Liu M, Wei C. Pharmacology effect of isoquercetin and its clinical application prospect. Chinese Pharmacy. 2010;21:2581–2583.
   Google Scholar
• QU WT, W ZHU, Zhai GY, et al. Research progress of synthesis and biological activity of quercetin derivatives. Chem Res. 2010;23:101–110.
   Google Scholar
• Gao X, Yanan J, Santhanam RK, et al. Garlic flavonoids alleviate H2O2 induced oxidative damage in L02 cells and induced apoptosis in HepG2 cells by Bcl‐2/caspase pathway. J Food Sci. 2021;86(2):366–375‏.
   PubMedGoogle Scholar
• Yokohira M, Yamakawa K, Saoo K, et al. Antioxidant effects of flavonoids used as food additives (purple corn color, enzymatically modified isoquercitrin, and isoquercitrin) on liver carcinogenesis in a rat medium‐term bioassay. J Food Sci. 2008;73(7):C561–C568‏.
   Google Scholar
• Uehara T, Ainslie GR, Kutanzi K, et al. Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. Toxicol Sci. 2013;132(1):53–63.
   PubMed Web of Science ®Google Scholar
• Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504–516‏.
   PubMed Web of Science ®Google Scholar
• Tolba R, Kraus T, Liedtke C, et al. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49(1):59–69.
   Google Scholar
• Bancroft JD, Gamble M. Theory and practice of histological technique. 5th ed. London: Churchill Livingstone Edinburg London; 2002.
   Google Scholar
• McLoughlin MR, Orlicky DJ, Prigge JR, et al. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy. Proc Natl Acad Sci U S A. 2019;116(23):11408–11417.
   Google Scholar
• Lane D, Levine A. p53 research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol. 2010;2(12):a000893.
   Google Scholar
• Schulze K, Imbeaud S, Letouzé E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47(5):505–511.
   PubMed Web of Science ®Google Scholar
• Ahmed OM, Ahmed AA, Fahim HI, et al. Quercetin and naringenin abate diethylnitrosamine/acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: the roles of oxidative stress, inflammation and cell apoptosis. Drug Chem Toxicol. 2019; 1–12.
   Web of Science ®Google Scholar
• Veeraraghavan VP, Mohan SK, Jainu M, et al. Ameliorating effects of garcinia mangostana Linn pericarp extract on hepatic antioxidants in diethyl nitrosamine (DEN) induced hepatocellular carcinoma (HCC). Pharm Res. 2015;49(4):329–337.
   Google Scholar
• Ko E, Kim JS, Bae JW, et al. SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC. Redox Biol. 2019;24:101217‏.
   Google Scholar
• Kuznietsova H, Dziubenko N, Herheliuk T, et al. Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat. Pharmaceutics. 2020;12(9):794.
   Google Scholar
• Ding YF, Wu ZH, Wei YJ, et al. Hepatic inflammation-fibrosis- cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. J Cancer Res Clin Oncol. 2017;143(5):821–834.
   PubMed Web of Science ®Google Scholar
• Hann HW, Wan S, Myers RE, et al. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PloS one. 2012;7(10):47687.
   Google Scholar
• Abozaid O, Moawed F, Salah Kawara R. Protective effect of benzethonium chloride on diethylnitrosamine-induced hepatocellular carcinoma. Benha. Vet Med J. 2018;35(2):537–546.
   Google Scholar
• Elsayed MM, Mostafa ME, Alaaeldin E, et al. Design and characterisation of novel sorafenib-loaded carbon nanotubes with distinct tumour-suppressive activity in hepatocellular carcinoma. Int J Nanomedicine. 2019;14:8445.
   PubMed Web of Science ®Google Scholar
• Clawson GA. Mechanisms of carbon tetrachloride hepatotoxicity. Pathol Immunopathol Res. 1989;8(2):104–112
   PubMedGoogle Scholar
• Bağırsakçı E, Şahin E, Atabey N, et al. Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology. 2017;93(2):136–142.
   PubMed Web of Science ®Google Scholar
• Morse MA, Sun W, Kim R, et al. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912–920.
   PubMed Web of Science ®Google Scholar
• Anwar HM, Moghazy AM, Osman AAE, et al. The therapeutic effect of myrrh (Commiphora molmol) and doxorubicin on diethylnitrosamine induced hepatocarcinogenesis in male albino rats. Asian Pac J Cancer Prev. 2013;22(7):2153–2163‏.
   Google Scholar
• Zakaria S, Helmy MW, Salahuddin A, et al. Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: a possible role of HGF/pAkt/STAT3 axis and VEGF. Biomed Pharmacother. 2018;108:65–75.
   PubMed Web of Science ®Google Scholar
• Rak J, Mitsuhashi Y, Bayko L, et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995;55(20):4575–4580.
   PubMed Web of Science ®Google Scholar
• Bedeer A, El-Rashidy M, Elzayat S, et al. Evaluation of the prognostic significance of P53 and proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma. Int J Cancer Biomed Res. 2020;4(3): 169–176.
   Google Scholar
• Sánchez DI, González‐Fernández B, San‐Miguel B, et al. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1‐phosphate signaling pathway in a mouse model of diethylnitrosamine‐induced hepatocellular carcinoma. J Pineal Res. 2017;62(1):12369.
   Google Scholar
• Ramirez JE, Zambrano R, Sepúlveda B, et al. Anthocyanins and antioxidant capacities of six Chilean berries by HPLC–HR-ESI-ToF-MS. Food Chem. 2015;176:106–114.
   PubMed Web of Science ®Google Scholar
• Appleton J. Evaluating the bioavailability of isoquercetin. Nat Med J. 2010;2(1):1–6.
   Google Scholar
• De Araújo MEMB, Franco YEM, Alberto TG, et al. Enzymatic de-glycosylation of rutin improves its antioxidant and antiproliferative activities. Food Chem. 2013;141(1):266–273.
   PubMed Web of Science ®Google Scholar
• Di Camillo Orfali G, Duarte AC, Bonadio V, et al. Review of anticancer mechanisms of isoquercitin. World J Clin Oncol. 2016;7(2):189.
   Google Scholar
• Li R, Yuan C, Dong C, et al. In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney. Naunyn Schmiedebergs Arch Pharmacol. 2011;383(5):437–445‏.
   Web of Science ®Google Scholar
• Chen F, Chen X, Yang D, et al. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways. Oncol Rep. 2016;36(1):165–172‏.
   PubMed Web of Science ®Google Scholar
• Abolmaesoomi M, Aziz AA, Junit SM, et al. Effects of solvent polarity on antioxidant and anti-proliferative activities in breast and colon cancer cells. Eur J Integr Med. 2019;28:57–67.
   Google Scholar
• El-Far YM, Khodir AE, Noor AO, et al. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro. Redox Rep. 2020;25(1):17–25.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhang X, Xu W, et al. Targeting the vasculature in hepatocellular carcinoma treatment: starving versus normalizing blood supply. Clin Transl Gastroenterol. 2017;8(6):98.
   PubMedGoogle Scholar
• Luo M, Yang F, Huang SX, et al. Two- stage model of chemically induced hepatocellular carcinoma in mouse. Cancer Commun. 2012;20(11):517–528.
   Google Scholar